Order Article Reprints

Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, Cortellini A, Addeo A, Escriu C, McKenzie H, et al. The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. International Journal of Molecular Sciences. 2023; 24(2):1746. https://doi.org/10.3390/ijms24021746

Anpalakhan, Shobana, Prerana Huddar, Roya Behrouzi, Alessio Signori, Judith Cave, Charles Comins, Alessio Cortellini, Alfredo Addeo, Carles Escriu, Hayley McKenzie, and et al. 2023. "The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study" International Journal of Molecular Sciences 24, no. 2: 1746. https://doi.org/10.3390/ijms24021746

Anpalakhan, S., Huddar, P., Behrouzi, R., Signori, A., Cave, J., Comins, C., Cortellini, A., Addeo, A., Escriu, C., McKenzie, H., Barone, G., Murray, L., Bhatnagar, G., Pinato, D. J., Ottensmeier, C., Gomes, F., & Banna, G. L. (2023). The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. International Journal of Molecular Sciences, 24(2), 1746. https://doi.org/10.3390/ijms24021746